Treatment of Ulcerative Colitis With Rectal Instillation of Qinghua Quyu Prescription(QHQYP)

Korábbi kezelés

• Patients currently participating in other clinical trials of medications.

Más betegség

• Patients with severe disease condition.
• Patients with infectious colonic diseases such as chronic schistosomiasis, bacterial dysentery, amoebic dysentery, intestinal tuberculosis, as well as non-infectious colonic diseases such as Crohn's disease, ischemic bowel disease, and radiation enteritis.
• Patients with serious complications such as local stenosis, intestinal obstruction, intestinal perforation, rectal polyps, toxic megacolon, colon cancer, rectal cancer, and anal diseases.
• Patients with severe primary heart, liver, lung, kidney, blood or other severe diseases that affect their survival.
• Patients with suspected or confirmed history of alcohol or drug abuse.
• Other conditions that may reduce the likelihood of enrollment or complicate enrollment, as determined by the researcher, such as frequent changes in work environment that may lead to loss of follow-up.
• Patients with allergies to two or more drugs or foods, or with a history of allergy to the components of this medication.

Egyéb

• Pregnant or lactating women.
• Patients with disabilities as defined by law (blind, deaf, mute, intellectually disabled, mentally ill, physically disabled).

• Meets the diagnostic criteria for active ulcerative colitis, with clinical severity being mild or moderate and the lesion range being limited to the rectum or left colon and not extending beyond the splenic flexure.
• Traditional Chinese medicine diagnosis indicates the presence of damp-heat syndrome in the large intestine.
• Between the ages of 18 and 65, regardless of gender.
• Informed consent and voluntary participation are required. The process of obtaining informed consent should comply with GCP regulations.